Sale

Market Size

Global Health Economics and Outcomes Research (HEOR) Market: By Service Type: Health Economic Services, Outcomes Research Services; By Applications: Oncology, Cardiovascular Diseases, Infectious Diseases, Neurology, Others; By End User: Pharmaceutical Companies, Others; Regional Analysis; Supplier Landscape: 2024-2032

Global Health Economics and Outcomes Research Market Size

The global health economics and outcomes research market was valued at USD 1.56 billion in 2023, driven by the rising drug development and clinical trials across the globe. The market is expected to grow at a CAGR of 12.50% during the forecast period of 2024-2032, with the values likely to attain a value of USD 4.50 billion by 2032.

 

Health Economics and Outcomes Research (HEOR) Market Report Snapshots

Health Economics and Outcomes Research (HEOR) Market Size

Health Economics and Outcomes Research (HEOR) Market Analysis

Health Economics and Outcomes Research (HEOR) Companies

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Health Economics and Outcomes Research (HEOR) Market Overview 

    3.1    Global Health Economics and Outcomes Research (HEOR) Market Historical Value (2017-2024) 
    3.2    Global Health Economics and Outcomes Research (HEOR) Market Forecast Value (2024-2032)
4    Global Health Economics and Outcomes Research (HEOR) Market Landscape
    4.1    Global Health Economics and Outcomes Research (HEOR) Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Health Economics and Outcomes Research (HEOR) Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Applications
5    Global Health Economics and Outcomes Research (HEOR) Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Health Economics and Outcomes Research (HEOR) Market Segmentation 
    6.1    Global Health Economics and Outcomes Research (HEOR) Market by Service Type
        6.1.1    Market Overview
        6.1.2    Health Economic Services
        6.1.3    Outcomes Research Services
    6.2    Global Health Economics and Outcomes Research (HEOR) Market by Applications
        6.2.1    Market Overview
        6.2.2    Oncology
        6.2.3    Cardiovascular Diseases
        6.2.4    Infectious Diseases
        6.2.5    Neurology
        6.2.6    Others
    6.3    Global Health Economics and Outcomes Research (HEOR) Market by End User
        6.3.1    Market Overview
        6.3.2    Pharmaceutical Companies
        6.3.3    Biotechnology Companies
        6.3.4    Healthcare Payers
        6.3.5    Healthcare Providers
    6.4    Global Health Economics and Outcomes Research (HEOR) Market by Region
        6.4.1    Market Overview
        6.4.2    North America 
        6.4.3    Europe
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Health Economics and Outcomes Research (HEOR) Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Health Economics and Outcomes Research (HEOR) Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Health Economics and Outcomes Research (HEOR) Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Health Economics and Outcomes Research (HEOR) Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Health Economics and Outcomes Research (HEOR) Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Grants Analysis
    12.1    Analysis by year
    12.2    Analysis by Amount Awarded
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Grant Application
    12.5    Analysis by Funding Institute
    12.6    Analysis by NIH Departments
    12.7    Analysis by Recipient Organization 
13    Funding and Investment Analysis
    13.1    Analysis by Funding Instances
    13.2    Analysis by Type of Funding
    13.3    Analysis by Funding Amount
    13.4    Analysis by Leading Players
    13.5    Analysis by Leading Investors
    13.6    Analysis by Geography
14    Regulatory Framework
    14.1    Regulatory Overview
        14.1.1    US FDA
        14.1.2    EU EMA
        14.1.3    INDIA CDSCO
        14.1.4    JAPAN PMDA
        14.1.5    Others
15    Supplier Landscape
    15.1    Pharmerit International
        15.1.1    Financial Analysis
        15.1.2    Service Portfolio
        15.1.3    Demographic Reach and Achievements
        15.1.4    Mergers and Acquisition
        15.1.5    Certifications
    15.2    ICON plc
        15.2.1    Financial Analysis
        15.2.2    Service Portfolio
        15.2.3    Demographic Reach and Achievements
        15.2.4    Mergers and Acquisition
        15.2.5    Certifications
    15.3    IQVIA
        15.3.1    Financial Analysis
        15.3.2    Service Portfolio
        15.3.3    Demographic Reach and Achievements
        15.3.4    Mergers and Acquisition
        15.3.5    Certifications
    15.4    Optum, Inc.
        15.4.1    Financial Analysis
        15.4.2    Service Portfolio
        15.4.3    Demographic Reach and Achievements
        15.4.4    Mergers and Acquisition
        15.4.5    Certifications
    15.5    Precision Xtract
        15.5.1    Financial Analysis
        15.5.2    Service Portfolio
        15.5.3    Demographic Reach and Achievements
        15.5.4    Mergers and Acquisition
        15.5.5    Certifications
    15.6    Cornerstone Research Group
        15.6.1    Financial Analysis
        15.6.2    Service Portfolio
        15.6.3    Demographic Reach and Achievements
        15.6.4    Mergers and Acquisition
        15.6.5    Certifications
    15.7    Xcenda
        15.7.1    Financial Analysis
        15.7.2    Service Portfolio
        15.7.3    Demographic Reach and Achievements
        15.7.4    Mergers and Acquisition
        15.7.5    Certifications
    15.8    Analysis Group
        15.8.1    Financial Analysis
        15.8.2    Service Portfolio
        15.8.3    Demographic Reach and Achievements
        15.8.4    Mergers and Acquisition
        15.8.5    Certifications
    15.9    Creativ-Ceutical
        15.9.1    Financial Analysis
        15.9.2    Service Portfolio
        15.9.3    Demographic Reach and Achievements
        15.9.4    Mergers and Acquisition
        15.9.5    Certifications
    15.10    HERON Group
        15.10.1    Financial Analysis
        15.10.2    Service Portfolio
        15.10.3    Demographic Reach and Achievements
        15.10.4    Mergers and Acquisition
        15.10.5    Certifications
    15.11    Oxford PharmaGenesis
        15.11.1    Financial Analysis
        15.11.2    Service Portfolio
        15.11.3    Demographic Reach and Achievements
        15.11.4    Mergers and Acquisition
        15.11.5    Certifications
    15.12    Cornerstone Research
        15.12.1    Financial Analysis
        15.12.2    Service Portfolio
        15.12.3    Demographic Reach and Achievements
        15.12.4    Mergers and Acquisition
        15.12.5    Certifications
    15.13    Evidera
        15.13.1    Financial Analysis
        15.13.2    Service Portfolio
        15.13.3    Demographic Reach and Achievements
        15.13.4    Mergers and Acquisition
        15.13.5    Certifications
    15.14    PRMA Consulting
        15.14.1    Financial Analysis
        15.14.2    Service Portfolio
        15.14.3    Demographic Reach and Achievements
        15.14.4    Mergers and Acquisition
        15.14.5    Certifications
    15.15    CHEORS
        15.15.1    Financial Analysis
        15.15.2    Service Portfolio
        15.15.3    Demographic Reach and Achievements
        15.15.4    Mergers and Acquisition
        15.15.5    Certifications
16    Model (Additional Insight)
    16.1    Overview 
    16.2    Potential Distributors 
    16.3    Key Parameters for Distribution Partner Assessment 
17    Key Opinion Leaders (KOL) Insights (Additional Insight)
18    Company Competitiveness Analysis (Additional Insight)

    18.1    Very Small Companies
    18.2    Small Companies
    18.3    Mid-Sized Companies
    18.4    Large Companies
    18.5    Very Large Companies
19    Payment Methods (Additional Insight)
    19.1    Government Funded
    19.2    Private Insurance
    19.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 1.56 billion in 2023, driven by increasing emphasis on drug development and clinical trials across the globe.

The market is anticipated to grow at a CAGR of 12.50% during the forecast period of 2024-2032, likely to reach a market value of USD 4.50 billion by 2032.

The market demand is driven by the increasing number of clinical trials for effective drug development and the rising focus of prominent companies to outsources services to as to expediate the drug development process, along with making it cost effective.

The current market trend includes the increasing mergers and acquisitions among several key companies. For instance, Kaiser Permanente and Geisinger announced their merger in April 2023, which aims at offering community-based healthcare services.

Major services include health economic services and outcomes research services.

The research finds wide applications in oncology, cardiovascular diseases, infectious diseases, and neurology, among others. 

Major end users include healthcare providers, pharmaceutical and biotech companies, and healthcare payers.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.

Key players involved in the market are Pharmerit International, ICON plc, IQVIA, Optum, Inc., Precision Xtract, Cornerstone Research Group, Xcenda, Analysis Group, Creativ-Ceutical, HERON Group, Oxford PharmaGenesis, Cornerstone Research, Evidera, PRMA Consulting and CHEORS.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER